YBX1 and breast carcinoma: It has been revealed that endogenous tRFs derived from human breast cancer cells could suppress breast cancer in vitro and in vivo by targeting YBX1 mRNA, suggesting that tRFs could target signaling pathways related to cell proliferation, thus enabling an effective intervention with the treatment of cancers (28).